The effect of a mouldable writing aid on older adults with hand osteoarthritis: a randomised controlled trial.

Not Applicable

Completed

• Conditions: Hand osteoarthritis; Musculoskeletal - Osteoarthritis

• Registration Number: ACTRN12614000947606
• Lead Sponsor: nitec Institute of Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-09-04
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Osteoarthritis in writing hand.
Reside in Auckland, NZ.

Exclusion Criteria

Cognitive impairments that may affect their ability to perform a handwriting assessment.
Hand surgery within the last six months.
Current treatment with cortisone.
Latex allergy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Writing quality as measured by the Handwriting Assessment Battery for adults (McCluskey & Lannin, 2003).[Baseline and 8 weeks after intervention commencement.]

Secondary Outcome Measures

Name	Time	Method
Modified Health Assessment Questionnaire - to measure quality of life for those with arthritis.[Baseline and 8 weeks after intervention commencement.];Count of joints affected by osteoarthritis of the hand. Hands will be examined for the occurrence of bony enlargements (1= present, 0= absent) and will be calculated as a summary of signs in both hands (range 0 to 30). The American College of Rheumatology criteria (Altman et al., 1990) will also be used as a diagnosis confirmation of hand osteoarthritis.<br>[Baseline and 8 weeks after intervention commencement.];Australian/Canadian hand index (AUSCAN) - self reported Likert scales for hand pain, stiffness and physical functioning.[Baseline and 8 weeks after intervention commencement.];Measure of Assistive Technology use scale- Likert scale assessing use of devices and 100mm VAS scale for comfort with assistive technology.[Baseline and 8 weeks after intervention commencement]